Amundi
CLX icon

Amundi’s Clorox CLX Stock Holding History

Amundi’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.2M Buy
860,903
+113,123
+15% +$10.9M 0.02% 514
2026
Q1 		$77.5M Buy
747,780
+129,165
+21% +$14.6M 0.02% 501
2025
Q4 		$62.4M Sell
618,615
-61,492
-9% -$6.68M 0.02% 586
2025
Q3 		$80.7M Sell
680,107
-260,292
-28% -$32.3M 0.03% 452
2025
Q2 		$117M Buy
940,399
+10,108
+1% +$1.35M 0.04% 382
2025
Q1 		$138M Sell
930,291
-101,992
-10% -$15.6M 0.05% 329
2024
Q4 		$166M Buy
1,032,283
+308,234
+43% +$50.4M 0.06% 310
2024
Q3 		$116M Buy
724,049
+26,434
+4% +$3.92M 0.04% 365
2024
Q2 		$92.4M Sell
697,615
-160,961
-19% -$22.4M 0.04% 395
2024
Q1 		$123M Buy
858,576
+335,731
+64% +$50.1M 0.05% 340
2023
Q4 		$73.9M Sell
522,845
-110,332
-17% -$14.7M 0.03% 448
2023
Q3 		$77.5M Sell
633,177
-43,889
-6% -$6.67M 0.04% 404
2023
Q2 		$109M Sell
677,066
-36,642
-5% -$5.91M 0.05% 342
2023
Q1 		$112M Buy
713,708
+260,080
+57% +$39M 0.06% 328
2022
Q4 		$64.4M Sell
453,628
-230,428
-34% -$32.7M 0.04% 453
2022
Q3 		$90.1M Buy
684,056
+211,193
+45% +$30.5M 0.05% 361
2022
Q2 		$69.8M Buy
472,863
+5,048
+1% +$721K 0.06% 347
2022
Q1 		$68.4M Sell
467,815
-74,853
-14% -$11.5M 0.05% 393
2021
Q4 		$99.3M Buy
542,668
+77,576
+17% +$12.9M 0.06% 317
2021
Q3 		$77M Sell
465,092
-183,919
-28% -$31.7M 0.05% 349
2021
Q2 		$117M Buy
+649,011
New +$118M 0.08% 255

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Amundi's CLX Position: Q2 2026 in Review

Amundi increased its Clorox (CLX) stake by 15% in Q2 2026, buying an estimated $10.9M and bringing the position to 860,903 shares worth $82.2M. The position accounts for 0.02% of the portfolio, ranked #514.

Amundi first reported a position in CLX in Q2 2021 and has held it in 21 quarters since. The position peaked at $166M in Q4 2024. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Amundi held 860,903 shares of Clorox worth $82.2M as of Q2 2026.
  • Amundi bought 113,123 Clorox shares in Q2 2026, an estimated $10.9M.
  • Clorox made up 0.02% of Amundi's portfolio in Q2 2026, its #514 holding.
  • Amundi first reported a position in Clorox in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Clorox position peaked at $166M in Q4 2024.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.